Keisuke Sato Selected Research

HLA-DR53

12/2012	A naturally processed HLA-DR-bound peptide from the IL-9 receptor alpha of HTLV-1-transformed T cells serves as a T helper epitope.
5/2005	Recognition of prostate and breast tumor cells by helper T lymphocytes specific for a prostate and breast tumor-associated antigen, TARP.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keisuke Sato Research Topics

Disease

30	Neoplasms (Cancer) 05/2024 - 08/2002
8	Diabetic Neuropathies (Diabetic Neuropathy) 04/2021 - 01/2013
7	Periodontitis 01/2021 - 08/2016
5	T-Cell Lymphoma (Lymphoma, T Cell) 12/2012 - 10/2004
4	Stroke (Strokes) 10/2023 - 12/2021
4	Inflammation (Inflammations) 01/2019 - 04/2003
4	Lymphoma (Lymphomas) 12/2012 - 10/2004
3	Hip Fractures (Intertrochanteric Fractures) 06/2023 - 01/2022
3	Fever (Fevers) 01/2022 - 08/2009
3	Neoplasm Metastasis (Metastasis) 12/2019 - 06/2009
3	Infections 01/2019 - 03/2009
3	T-Cell Leukemia (Leukemia, T Cell) 12/2012 - 10/2004
3	Prostatic Neoplasms (Prostate Cancer) 06/2007 - 11/2003
3	Breast Neoplasms (Breast Cancer) 07/2006 - 08/2002
2	Cerebral Infarction 01/2024 - 10/2023
2	Disease Progression 07/2023 - 08/2009
2	Hepatocellular Carcinoma (Hepatoma) 08/2022 - 01/2020
2	Sarcopenia 03/2021 - 01/2021
2	Dysbiosis 01/2021 - 01/2021
2	Rectal Neoplasms (Rectal Cancer) 12/2020 - 12/2019
2	Hemorrhage 12/2020 - 01/2019
2	Liver Cirrhosis (Hepatic Cirrhosis) 04/2020 - 06/2018
2	Esophageal Neoplasms (Esophageal Cancer) 01/2020 - 01/2017
2	Arthritis (Polyarthritis) 12/2019 - 01/2017
2	Fibrosis (Cirrhosis) 01/2019 - 06/2018
2	Insulin Resistance 08/2016 - 01/2016
2	Hypersensitivity (Allergy) 07/2016 - 11/2007
2	Lung Neoplasms (Lung Cancer) 09/2015 - 11/2011
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2012 - 10/2004
2	Urinary Bladder Neoplasms (Bladder Cancer) 07/2010 - 05/2010
2	Melanoma (Melanoma, Malignant) 06/2009 - 06/2007
2	Leukemia 07/2006 - 12/2005
1	Anaphylaxis (Anaphylactic Shock) 07/2023
1	Congenital Heart Defects (Congenital Heart Defect) 01/2023
1	Cognitive Dysfunction 01/2023
1	Atrioventricular Block 01/2023
1	COVID-19 related pediatric multisystem inflammatory disease 01/2023
1	Malnutrition (Nutritional Deficiencies) 04/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Cysts 01/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2022
1	Back Pain (Backache) 01/2022

Drug/Important Bio-Agent (IBA)

16	AntigensIBA 01/2023 - 08/2002
13	Peptides (Polypeptides)IBA 02/2014 - 12/2002
12	EpitopesIBA 12/2012 - 12/2002
9	Proteins (Proteins, Gene)FDA Link 08/2018 - 08/2002
7	epalrestatIBA 01/2022 - 01/2013
5	Messenger RNA (mRNA)IBA 01/2023 - 04/2004
5	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 11/2011 - 10/2004
4	Aldehyde Reductase (Aldose Reductase)IBA 01/2022 - 01/2013
4	VaccinesIBA 12/2012 - 11/2003
3	Biomarkers (Surrogate Marker)IBA 10/2021 - 06/2018
3	AutoantigensIBA 01/2017 - 10/2004
3	HLA-DR15 antigenIBA 12/2012 - 10/2004
3	Immunoglobulin G (IgG)IBA 08/2009 - 08/2002
3	Complementary DNA (cDNA)IBA 12/2007 - 08/2002
2	Indicators and Reagents (Reagents)IBA 03/2021 - 01/2020
2	Interleukin-17 (Interleukin 17)IBA 03/2020 - 01/2017
2	SteroidsIBA 08/2018 - 08/2009
2	CytokinesIBA 01/2018 - 08/2009
2	HydrogelsIBA 01/2016 - 02/2014
2	Advanced Glycation End ProductsIBA 01/2015 - 01/2013
2	glycolaldehydeIBA 01/2015 - 01/2013
2	HLA-DR53IBA 12/2012 - 05/2005
2	Membrane Proteins (Integral Membrane Proteins)IBA 05/2010 - 02/2008
2	AntibodiesIBA 08/2009 - 07/2006
2	HLA-DR9 antigenIBA 05/2005 - 10/2004
1	gadolinium ethoxybenzyl DTPA FDA Link 05/2024
1	Risperidone (Risperdal Consta)FDA LinkGeneric 07/2023
1	Epinephrine (Adrenaline)FDA LinkGeneric 07/2023
1	Adrenergic Agents (Adrenergic Drugs)IBA 07/2023
1	SolutionsIBA 07/2023
1	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 07/2023
1	Atropine FDA LinkGeneric 01/2023
1	BNT162 VaccineIBA 01/2023
1	Carcinoembryonic AntigenIBA 01/2023
1	PowdersIBA 08/2022
1	Metronidazole (Metric)FDA LinkGeneric 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	NivolumabIBA 01/2022

Therapy/Procedure

15	Immunotherapy 12/2012 - 08/2002
7	Activities of Daily Living (ADL) 01/2024 - 01/2021
5	Drug Therapy (Chemotherapy) 01/2022 - 10/2004
4	Therapeutics 08/2018 - 01/2009
3	Oral Administration 08/2022 - 03/2020
2	Stroke Rehabilitation 01/2024 - 12/2021
2	Length of Stay 10/2023 - 01/2022
2	Ligation 01/2021 - 12/2019
2	Stents 01/2021 - 12/2020
2	Chemoradiotherapy 12/2020 - 12/2019
2	CT protocol 04/2020 - 06/2018
2	Esophagectomy 01/2020 - 01/2017
2	Neoadjuvant Therapy 12/2019 - 06/2018
2	Artificial Respiration (Mechanical Ventilation) 01/2006 - 07/2002
1	Blalock-Taussig Procedure 01/2023
1	Catheters 01/2023
1	Palliative Care (Palliative Therapy) 01/2023
1	Foot Orthoses 03/2022
1	Exercise Therapy (Therapy, Exercise) 01/2022